欲千北

我不是专业医生,但对防病治病有兴趣,想多向大家交流,学习,多蒙恩惠。
个人资料
正文

腺病毒新冠疫苗 · 血栓

(2021-04-12 22:31:28) 下一个

英国药监局(MHRA)4月7日指出,有79人注射牛津疫苗后出现血栓,并发血小板降低,其中女性约占2/3。其中有19人因血栓死亡。死者年龄18-79,其中50岁以下有11人,30岁以下有3人。药监局怀疑疫苗与血栓有一定关联,具体血栓发生机理不清楚。考虑到已经有2千万剂疫苗的注射量,血栓发生率非常低。

腺病毒感染宿主细胞有选择性,一些种类的腺病毒以细胞膜上的 CD46 蛋白为受体进入细胞。J&J 疫苗采用的腺病毒载具Ad26, 牛津大学和AstraZeneca 公司的腺病毒载具ChAdOx1,都是以 CD46 为受体。J&J的载具原型是一种人体腺病毒,英国牛津的载具原型是人工修饰过的黑猩猩腺病毒。

膜蛋白 CD46 可抑制补体激活。补体是一种非特异性免疫保护系统,与细胞裂解和血凝/血栓关系密切。CD46广泛存在于人体细胞。如果没有 CD46,补体系统活性升高,容易血栓。觉得牛津疫苗可能通过 CD46,而与血栓有关联。

参看

MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, https://www.gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots

Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457266/

Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic, https://www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915

News & Views: Getting Familiar with COVID-19 Adenovirus-replication-deficient Vaccines, https://www.chop.edu/news/news-views-getting-familiar-covid-19-adenovirus-replication-deficient-vaccines

Complement Activation on Platelets Correlates with a Decrease in Circulating Immature Platelets in Patients with Immune Thrombocytopenic Purpura,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004348/

[ 打印 ]
阅读 ()评论 (0)
评论
目前还没有任何评论
登录后才可评论.